Analytical Data
-
Gene name
CS
- Application
-
Alternative Names
CS；UPF0449 Protein C19orf25
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9UFG5
-
Expression Region
1-118aa
-
AA Sequence
MGSKAKKRVL LPTRPAPPTV EQILEDVRGA PAEDPVFTIL APEDPPVPFR MMEDAEAPGE QLYQQSRAYV AANQRLQQAG NVLRQRCELL QRAGEDLERE VAQMKQAALP AAEAASSG
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of CS (Chondroitin Sulfate) recombinant proteins has gained significant attention in the fields of biochemistry and molecular biology due to their crucial roles in various biological processes and potential therapeutic applications. Chondroitin sulfate, a glycosaminoglycan, is a key component of the extracellular matrix and plays an essential role in cell signaling, proliferation, and tissue repair. Research on CS recombinant proteins focuses on understanding their structure-function relationships, which can provide insights into their biological roles and mechanisms. Additionally, CS has been implicated in various pathologies, including cancer, osteoarthritis, and central nervous system disorders, making it a target for drug development. The ability to produce recombinant CS proteins using techniques such as genetic engineering allows for the study of specific molecular interactions and the exploration of their therapeutic potential. By generating stable, high-yield production systems, researchers aim to develop CS-based biomaterials and therapeutics that can aid in regenerative medicine and improve treatment options for patients with degenerative diseases. This research is important not only for advancing our understanding of CS biology but also for harnessing its potential in clinical applications, including drug delivery systems, tissue engineering, and as a biomarker for disease diagnosis. Overall, the exploration of CS recombinant proteins represents a promising area of study with the potential to contribute significantly to both fundamental science and translational medicine.
